Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin (CI-1008) In The Treatment For Pain Associated With Diabetic Peripheral Neuropathy
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin (CI-1008) In The Treatment For Pain Associated With Diabetic Peripheral Neuropathy
To evaluate the efficacy and safety of pregabalin at 300 mg/day and 600 mg/day (BID) in patients with painful diabetic peripheral neuropathy.
Inclusion Criteria:
Exclusion Criteria:
Date-shi, Fukushima, Japan
Shirakawa-shi, Fukushima, Japan
Ebetu, Hokkaido, Japan
Yamada, Okayama-ken, Japan
Tomishiro, Okinawa, Japan
Hirano-ku, Osaka, Japan
Suminoe-ku, Osaka, Japan
Sunto-gun, Shizuoka, Japan
Oyama-shi, Tochigi, Japan
Bunkyo-ku, Tokyo, Japan
Chiyoda-ku, Tokyo, Japan
Chuo-ku, Tokyo, Japan
Minato-ku, Tokyo, Japan
Ohta-ku, Tokyo, Japan
Shibuya-ku, Tokyo, Japan